Chimera is a GLP / GCP certified bioanalytical CRO and immunoassay platform provider specialized in ultra sensitive large-molecule bioanalysis

We are a specialty CRO for ultra sensitive and technically demanding bioanalysis, and the world’s leading Immuno-PCR based technology vendor.

Beginning with our proprietary Imperacer® (Immuno-PCR) platform, which combines immunoassay specificity with an exponential PCR read-out, Chimera offers services on several highly sensitive platforms that go beyond the capabilities of conventional ELISA. Since 2000, we’ve built our name specializing in supporting drug development programs with the greatest demands on sensitivity and bioanalytical quality.

As service provider for extremely sensitive immunoassays, we are constantly evaluating emerging bioanalytical platforms to extend our expertise and platform portfolio to deliver immunoassay performance exceeding your highest expectations.

A Ph.D. level project manager will be your key contact person to ensure that our dedicated team of scientists is working to fulfill your study requirements with the highest quality and swift turnaround.

Originating from Greek mythology, the word chimera refers to a hybrid creature whose body is composed of the physiological features of several distinct animals. In this analogy, the core reagents in our proprietary Imperacer® technology are our chimeric antibody-DNA conjugates, which combine the specificity of antibody-target binding with the exponential signal amplification of DNA analysis.